Nvidia vs. Broadcom: The Smarter AI Stock to Buy in April

Nvidia projects lifetime sales of Blackwell and upcoming Vera Rubin chips of $1.0 trillion by end-2027 (up from a prior $500B by 2026), implying material upside to chip demand; Broadcom expects custom AI chips to generate $100B by end-2027. Broadcom's AI-custom-chip division grew 106% to $8.4B last quarter, suggesting at least a triple in revenue for that segment is feasible. The author prefers Nvidia as the better buy for April due to superior growth and a cheaper forward P/E, but flags geopolitical risk (Iran) as a potential determinant of near-term risk appetite.

Analysis

Nvidia’s next-gen efficiency step (fewer chips per workload) creates a classic paradox: per-unit HBM and socket demand falls, but total system spend and aggregate silicon demand can rise if customers scale deployments to maximize throughput per dollar. That amplifies the upside for companies owning the accelerated compute stack (Nvidia, TSMC, HBM vendors) while increasing pressure on vendors whose value rests on general-purpose servers or low-margin OEM integration.

Broadcom’s bespoke ASIC model exploits hyperscalers’ marginal economics: once a hyperscaler validates an ASIC for a narrow high-volume workload, that vendor locks in a lower structural unit cost and higher switching costs, compressing GPU TAM for those tasks. The second-order effect: foundry mix shifts toward mature nodes for certain ASICs, relieving some leading-edge capacity constraints but concentrating HBM, interconnect, and packaging demand into fewer large customers, increasing counterparty concentration risk for memory and substrate suppliers.

Key risks are asymmetric and idiosyncratic: (1) timeline slippage or benchmark underperformance of Rubin or Broadcom designs can compress earnings expectations quickly; (2) geopolitics and export controls can choke foundry access or hyperscaler demand in single quarters; (3) a faster-than-expected pivot by hyperscalers to custom ASICs would materially lower Nvidia’s long-term TAM for inference. Monitor design-win cadence (quarterly disclosures), foundry capacity booking signals, and large hyperscaler capex cadence over the next 3–12 months.

Key Decisions for Investors

• Long NVDA (base position): Buy an asymmetric call spread with ~9–15 month tenor (e.g., Jan–Dec 2027 call spread sized to 2–3% portfolio). Rationale: captures Rubin-driven re-rating while capping premium outlay. Target upside 40–100% if Rubin accelerates bookings; downside limited to premium (expected loss ~2–3% of portfolio allocation).
• Tactical hedge around geopolitics: Buy short-dated NVDA 4–8 week puts 5–7% OTM sized to ~25% of long exposure prior to major geopolitical headlines (Iran/Middle East developments). Rationale: inexpensive insurance that pays during risk-off events that can knock AI high-multiple tech down 15–30%. Cost typically small (1–3% of notional) but provides concentrated protection.
• Selective long Broadcom (satellite position): Accumulate AVGO equity or a 12–24 month call spread sized to ~30% of NVDA exposure to play custom ASIC adoption at hyperscalers. Rationale: asymmetric capture of specialized ASIC adoption (lower volatility than NVDA). Expect 2x payoff if Broadcom secures multiple hyperscaler design wins; downside is standard equity drawdown—size to limit portfolio gamma.
• Memory/midstream play (second-order): Buy call spreads on a major HBM/DRAM supplier (size small, 6–18 month) to capture aggregate memory demand growth if AI deployment scales. Rationale: even with per-chip HBM reductions, total installed capacity is likely to grow materially if hyperscalers expand fleets. Risk: Rubin’s per-chip demand reduction could mute this trade in the near term—limit exposure to <1% portfolio and use spreads to cap downside.